Paragon Capital Management (Colorado)’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,261
Closed -$289K 224
2025
Q1
$289K Buy
+4,261
New +$255K 0.06% 132
2024
Q4
Sell
-5,070
Closed -$319K 195
2024
Q3
$319K Buy
5,070
+55
+1% +$3.21K 0.06% 117
2024
Q2
$296K Buy
+5,015
New +$314K 0.05% 98
2023
Q4
Sell
-3,370
Closed -$235K 180
2023
Q3
$235K Buy
3,370
+130
+4% +$9.21K 0.05% 143
2023
Q2
$224K Buy
+3,240
New +$231K 0.05% 173
2023
Q1
Sell
-2,332
Closed -$217K 187
2022
Q4
$217K Sell
2,332
-184
-7% -$17.8K 0.06% 142
2022
Q3
$240K Sell
2,516
-64
-2% -$6.33K 0.07% 94
2022
Q2
$239K Sell
2,580
-287
-10% -$28K 0.07% 100
2022
Q1
$290K Sell
2,867
-235
-8% -$24.7K 0.05% 96
2021
Q4
$320K Buy
3,102
+293
+10% +$27.1K 0.05% 88
2021
Q3
$238K Buy
2,809
+206
+8% +$17.3K 0.04% 110
2021
Q2
$217K Buy
+2,603
New +$213K 0.1% 98
2018
Q4
Sell
-3,754
Closed -$296K 206
2018
Q3
$296K Sell
3,754
-3
-0.1% -$214 0.25% 102
2018
Q2
$242K Sell
3,757
-2
-0.1% -$132 0.22% 166
2018
Q1
$234K Buy
+3,759
New +$270K 0.1% 193

Other funds holding CVS

Paragon Capital Management (Colorado)'s CVS Position: Q2 2025 in Review

Paragon Capital Management (Colorado) sold out of CVS Health (CVS) in Q2 2025, closing a stake of 4,261 shares — an estimated $289K sold.

Paragon Capital Management (Colorado) first reported a position in CVS in Q1 2018 and held it in 15 quarters. The position peaked at $320K in Q4 2021. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Paragon Capital Management (Colorado) reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Paragon Capital Management (Colorado) sold 4,261 CVS Health shares in Q2 2025, an estimated $289K.
  • Paragon Capital Management (Colorado) first reported a position in CVS Health in Q1 2018 and held it in 15 quarters.
  • Paragon Capital Management (Colorado)'s CVS Health position peaked at $320K in Q4 2021.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q2 2025, filed 16 Jul 2025.